Back to Journals » OncoTargets and Therapy » Volume 15

Ovarian Cancer Therapy: Homologous Recombination Deficiency as a Predictive Biomarker of Response to PARP Inhibitors

Total article views   HTML views PDF downloads Totals
7,413 Dovepress* 5,532+ 148 5,680
PubMed Central* 1,881 230 2,111
Totals 7,413 378 7,791
*Since 4 October 2022
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed Central and Google Scholar